Problems may arise from flaws in the drugs design, manufacturing defects, or inadequate warnings about potential side effects
Consult your provider if you experience severe or persistent nausea and vomiting that prevents adequate food or fluid intake, signs of pancreatitis including severe abdominal pain , vision changes or signs of diabetic retinopathy progression if you have diabetes, severe constipation lasting more than a week despite interventions, rapid heart rate or chest pain, or complete lack of appetite suppression or weight loss after reaching 1mg dose for at least four weeks
It is sometimes also called a labial lentigo or lip melanosis
That said, spending on Ozempic, Mounjaro, and Rybelsus is only included for patients who have an obesity diagnosis
Alternative medications like DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, sulfonylureas, and TZDs are available for managing blood sugar levels, but the suitability of these options should be determined by a healthcare professional
This umbrella review aimed to determine (1) whether GLP-1 RAs can relieve the development of MASLD and/or lead to safety problems, and (2) which indicators' resolution and/or safety problems were observed with GLP-1 RAs treatment